Mesenchymal stem cells in lumbar spine surgery: a single institution experience about red bone marrow and fat tissue derived MSCs

2016 ◽  
Vol 61 (2) ◽  
Author(s):  
Manolo Piccirilli ◽  
Catia P. Delfinis ◽  
Antonio Santoro ◽  
Maurizio Salvati
2012 ◽  
Vol 152 (4) ◽  
pp. 528-534 ◽  
Author(s):  
I. V. Maiborodin ◽  
V. A. Matveeva ◽  
I. S. Kolesnikov ◽  
M. N. Drovosekov ◽  
M. S. Toder ◽  
...  

2020 ◽  
Vol 65 (6) ◽  
pp. 1126-1134
Author(s):  
М.А. Плахотний ◽  
◽  
А.М. Кодунов ◽  
Е.В. Горина ◽  
В.В. Бояринцев ◽  
...  

The use of mesenchymal stem cells is an effective treatment strategy for a number of retinal degenerative diseases. Limited survival of these cells following transplantation remains a significant barrier in achieving a therapeutic effect. It has been shown earlier that hypoxia-grown mesenchymal stem cells display enhanced proliferative activity. We hypothesized that such cultivation condition could be beneficial for successful injection of these cells into the subretinal region. For this purpose, we isolated mesenchymal stem cells from mouse red bone marrow, described phenotypic characterization and the ability of these cells to chondrogenic, osteogenic and adipogenic differentiation, and proliferative activity in hypoxic (5% of oxygen in the atmosphere) and normoxic (21% of oxygen in the atmosphere) conditions. In the same manner, we isolated mesenchymal stem cells from red bone marrow obtained from GFP-expressing C57 black mice. After preliminary cultivation under normoxia (control cells) or hypoxia (experimental cells), the cells were loaded with magnetic particles and injected into the subretinal region of rabbit eyes...


2006 ◽  
Vol 19 (03) ◽  
pp. 133-141 ◽  
Author(s):  
H. van Bree ◽  
M. Tshamala

SummaryThe osteogenic potential of red bone marrow was first reported more than 100 years ago. Since then, studies have reported controversial results that do not confirm nor disprove the capacity of fresh red bone marrow to produce bone. Researches have been focused on techniques that improve the efficiency of the bone marrow, including: the increase of the concentration of the mesenchymal stem cells in the aspirated bone marrow, the combination with a ‘carrier’ that helps to maintain the mesenchymal stem cells and guides and supports the vascular ingrowth in the defect, or the combination with bone growth factors that stimulate the marrow stromal cells to differentiate into bone forming cells. Each of these techniques has its drawbacks and increases the expenses of an operation. On the other hand, the synergistic effect observed with these combinations does not resolve the problem of the osteogenic capacity of pure bone marrow, which still remains questionable.


2013 ◽  
Author(s):  
Melo Ocarino Natalia de ◽  
Silvia Silva Santos ◽  
Lorena Rocha ◽  
Juneo Freitas ◽  
Reis Amanda Maria Sena ◽  
...  

2014 ◽  
Author(s):  
Reis Amanda Maria Sena ◽  
Freitas Silva Juneo de ◽  
Silvia Silva Santos ◽  
Rogeria Serakides ◽  
Melo Ocarino Natalia de

Sign in / Sign up

Export Citation Format

Share Document